KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Shares Outstanding (2016 - 2025)

CareDx (CDNA) has disclosed Shares Outstanding for 13 consecutive years, with $50.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 7.04% to $50.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.9 million through Dec 2025, down 7.04% year-over-year, with the annual reading at $50.9 million for FY2025, 7.04% down from the prior year.
  • Shares Outstanding hit $50.9 million in Q4 2025 for CareDx, down from $51.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $55.5 million in Q1 2025 to a low of $50.9 million in Q4 2025.
  • Historically, Shares Outstanding has averaged $53.0 million across 5 years, with a median of $53.1 million in 2022.
  • Biggest five-year swings in Shares Outstanding: increased 20.73% in 2021 and later dropped 7.04% in 2025.
  • Year by year, Shares Outstanding stood at $52.9 million in 2021, then increased by 1.15% to $53.5 million in 2022, then decreased by 3.79% to $51.5 million in 2023, then increased by 6.34% to $54.8 million in 2024, then decreased by 7.04% to $50.9 million in 2025.
  • Business Quant data shows Shares Outstanding for CDNA at $50.9 million in Q4 2025, $51.4 million in Q3 2025, and $53.2 million in Q2 2025.